<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Belgium&#8217;s UCB set to purchase RA Pharmaceuticals	</title>
	<atom:link href="https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/</link>
	<description>UK Investor Magazine provides breaking financial news and investment ideas</description>
	<lastBuildDate>Mon, 18 Nov 2019 11:41:33 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>
		By: Consort Medical shares rocket on takeover offer - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12650</link>

		<dc:creator><![CDATA[Consort Medical shares rocket on takeover offer - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 18 Nov 2019 11:41:33 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12650</guid>

					<description><![CDATA[[&#8230;] This follows the same stream as RA Pharma (NASDAQ: RARX) and UCB (EBR: UCB) merging a few weeks back. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] This follows the same stream as RA Pharma (NASDAQ: RARX) and UCB (EBR: UCB) merging a few weeks back. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Verona Pharma widen third quarter loss - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12432</link>

		<dc:creator><![CDATA[Verona Pharma widen third quarter loss - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 05 Nov 2019 12:06:02 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12432</guid>

					<description><![CDATA[[&#8230;] UCB (EBR: UCB) are close to completing a move for RA Pharmaceuticals (NASDAQ: RARX), and the new super firm will pose strong competition to [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] UCB (EBR: UCB) are close to completing a move for RA Pharmaceuticals (NASDAQ: RARX), and the new super firm will pose strong competition to [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Indivior report third quarter profit drop - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12385</link>

		<dc:creator><![CDATA[Indivior report third quarter profit drop - UK Investor Magazine]]></dc:creator>
		<pubDate>Thu, 31 Oct 2019 12:45:48 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12385</guid>

					<description><![CDATA[[&#8230;] as competitors such as RA Pharmaceuticals (NASDAQ: RARX) and Belgian firm UCB (EBR: UCB) recently completed a merger, placing their dominance in the [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] as competitors such as RA Pharmaceuticals (NASDAQ: RARX) and Belgian firm UCB (EBR: UCB) recently completed a merger, placing their dominance in the [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: ConvaTec report solid Third Quarter results - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12345</link>

		<dc:creator><![CDATA[ConvaTec report solid Third Quarter results - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 30 Oct 2019 10:36:31 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12345</guid>

					<description><![CDATA[[&#8230;] The growth consolidates ConvaTec&#8217;s status in the against other medical supplier firms such as RA Pharmaceuticals (NASDAQ: RARX) and UBS (EBR: UCB) who are set to complete a merger in early 2020. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] The growth consolidates ConvaTec&#8217;s status in the against other medical supplier firms such as RA Pharmaceuticals (NASDAQ: RARX) and UBS (EBR: UCB) who are set to complete a merger in early 2020. [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Midatech Pharma reaches agreement with investor for $3 million stake - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12252</link>

		<dc:creator><![CDATA[Midatech Pharma reaches agreement with investor for $3 million stake - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 23 Oct 2019 09:50:44 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12252</guid>

					<description><![CDATA[[&#8230;] in the Pharma market RA Pharmaceuticals (NASDAQ: RARX) have received a takeover proposal from UBS (EBR: UCB), whilst Tissue [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] in the Pharma market RA Pharmaceuticals (NASDAQ: RARX) have received a takeover proposal from UBS (EBR: UCB), whilst Tissue [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Collagen Solutions sees third consecutive half of revenue growth - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12200</link>

		<dc:creator><![CDATA[Collagen Solutions sees third consecutive half of revenue growth - UK Investor Magazine]]></dc:creator>
		<pubDate>Tue, 22 Oct 2019 11:35:12 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12200</guid>

					<description><![CDATA[[&#8230;] the health sector, there have been updates to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: SLRX) [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the health sector, there have been updates to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: SLRX) [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Warnings of lower revenues drive Tissue Regenix stocks down - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12142</link>

		<dc:creator><![CDATA[Warnings of lower revenues drive Tissue Regenix stocks down - UK Investor Magazine]]></dc:creator>
		<pubDate>Thu, 17 Oct 2019 13:56:40 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12142</guid>

					<description><![CDATA[[&#8230;] the health sector, there have been updates to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: SLRX) [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the health sector, there have been updates to Ra Pharmaceuticals Inc (NASDAQ: RARX), Yourgene Health PLC (LON: YGEN), Salarius Pharmaceuticals Inc (NASDAQ: SLRX) [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Alexion set to buy Achillion Pharmaceuticals - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12105</link>

		<dc:creator><![CDATA[Alexion set to buy Achillion Pharmaceuticals - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 16 Oct 2019 13:05:07 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12105</guid>

					<description><![CDATA[[&#8230;] the health sector, there have been updates to RA Pharmaceuticals Inc (NASDAQ: RARX), TekCapital (LON: TEK) and Yourgene Health [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the health sector, there have been updates to RA Pharmaceuticals Inc (NASDAQ: RARX), TekCapital (LON: TEK) and Yourgene Health [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Tekcapital shares climb as Salarius succeeds - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12094</link>

		<dc:creator><![CDATA[Tekcapital shares climb as Salarius succeeds - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 16 Oct 2019 11:04:16 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12094</guid>

					<description><![CDATA[[&#8230;] the health sector, there have been updates on Ra Pharmaceuticals Inc (NASDAQ: RARX),  OptiBiotix Health Plc (LON: OPTI) and Yourgene Health Plc [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the health sector, there have been updates on Ra Pharmaceuticals Inc (NASDAQ: RARX),  OptiBiotix Health Plc (LON: OPTI) and Yourgene Health Plc [&#8230;]</p>
]]></content:encoded>
		
			</item>
		<item>
		<title>
		By: Yourgene set to hit growth target in half year update - UK Investor Magazine		</title>
		<link>https://ukinvestormagazine.co.uk/belgiums-ucb-set-to-purchase-ra-pharmaceuticals/#comment-12047</link>

		<dc:creator><![CDATA[Yourgene set to hit growth target in half year update - UK Investor Magazine]]></dc:creator>
		<pubDate>Mon, 14 Oct 2019 13:45:25 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestormagazine.co.uk/?p=22522#comment-12047</guid>

					<description><![CDATA[[&#8230;] the health sector, there have been updates on Ra Pharmaceuticals Inc (NASDAQ: RARX),  OptiBiotix Health Plc (LON: OPTI) and NMC Health (LON: [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] the health sector, there have been updates on Ra Pharmaceuticals Inc (NASDAQ: RARX),  OptiBiotix Health Plc (LON: OPTI) and NMC Health (LON: [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
